Categories
Emcure Pharmaceuticals Limited — Updates, 08-05-2026: General Updates
08-05-2026 · 01:16 pm
Emcure Pharma received an ESG rating of 21 for FY25 from NSE Sustainability. This independent assessment provides investors insight into the company's environmental, social, and governance performance.
No comments yet. Be the first to comment!